A panel of DNA methylation markers for the classification of consensus molecular subtypes 2 and 3 in patients with colorectal cancer

Consensus molecular subtypes (CMSs) can guide precision treatment of colorectal cancer (CRC). We aim to identify methylation markers to distinguish between CMS2 and CMS3 in patients with CRC, for which an easy test is currently lacking. To this aim, fresh‐frozen tumor tissue of 239 patients with sta...

Descripción completa

Detalles Bibliográficos
Autores principales: van den Berg, Inge, Smid, Marcel, Coebergh van den Braak, Robert R. J., van de Wiel, Mark A., van Deurzen, Carolien H. M., de Weerd, Vanja, Martens, John W. M., IJzermans, Jan N. M., Wilting, Saskia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637568/
https://www.ncbi.nlm.nih.gov/pubmed/34510716
http://dx.doi.org/10.1002/1878-0261.13098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637568/
https://www.ncbi.nlm.nih.gov/pubmed/34510716
http://dx.doi.org/10.1002/1878-0261.13098

Ejemplares similares